Creative Medical Technology Holdings, Inc.: Form 10-Q for the period ended Jun 30, 2018
Filed with the SEC on Aug 14, 2018 and accepted by EDGAR at Aug 14, 2018, 16:10 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-04-01 to 2018-06-30 | $4.8k | us-gaap:Revenues |
| Revenue | 6 months2018-01-01 to 2018-06-30 | $14.4k | us-gaap:Revenues |
| Cost of revenue | 3 months2018-04-01 to 2018-06-30 | $2.5k | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2018-01-01 to 2018-06-30 | $4.9k | us-gaap:CostOfRevenue |
| Gross profit | 3 months2018-04-01 to 2018-06-30 | $2.3k | us-gaap:GrossProfit |
| Gross profit | 6 months2018-01-01 to 2018-06-30 | $9.5k | us-gaap:GrossProfit |
| Research and development | 3 months2018-04-01 to 2018-06-30 | $4.2k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2018-01-01 to 2018-06-30 | $7.4k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2018-04-01 to 2018-06-30 | −$314.8k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-01-01 to 2018-06-30 | −$519.0k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-04-01 to 2018-06-30 | $413.0k | us-gaap:InterestExpense |
| Interest expense | 6 months2018-01-01 to 2018-06-30 | $604.3k | us-gaap:InterestExpense |
| Net income | 3 months2018-04-01 to 2018-06-30 | −$6.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months2018-01-01 to 2018-06-30 | −$14.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-04-01 to 2018-06-30 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2018-01-01 to 2018-06-30 | −$0.03 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months2018-01-01 to 2018-06-30 | −$409.7k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2018-06-30 | $100.5k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-06-30 | $105.3k | us-gaap:AssetsCurrent |
| Total assets | At period end2018-06-30 | $279.4k | us-gaap:Assets |
| Current liabilities | At period end2018-06-30 | $10.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-06-30 | $10.9m | us-gaap:Liabilities |
| Long-term debt | At period end2018-06-30 | $673.1k | us-gaap:LongTermDebt |
Source: SEC EDGAR, the filing index for accession 0001144204-18-044664. Last ingested by Listed: Nov 14, 2026, 19:08 ET. Listed shows no prices and gives no investment advice.